Rating History for Flexion Therapeutics (FLXN) by Northland

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/19/2021 Carl Byrnes Downgrade Market Perform
(Outperform)
N/A
(N/A)
9.12
(25.05)
174.67% Details